Guttalax (Sodium Picosulfate)

Guttalax is indicated for short‑term relief of occasional constipation and for bowel cleansing before certain diagnostic procedures.

• Relief of mild to moderate constipation in adults.
• Preparation of the colon for colonoscopy, sigmoidoscopy, or radiographic imaging.
• Adjunct to surgical bowel preparation when a rapid evacuation is required.
• Use in patients where bulk‑forming laxatives have been ineffective.
• May be employed in pediatric patients under medical supervision if approved locally.

The most frequently reported effects of sodium picosulfate are related to its laxative action and generally resolve after the bowel movement.

Common

• Abdominal cramping or discomfort.
• Increased gas or flatulence.
• Nausea or mild vomiting.
• Loose stools or mild diarrhea.

Serious

• Dehydration or marked fluid loss.
• Significant electrolyte disturbances such as low potassium.
• Rectal bleeding or severe abdominal pain.
• Allergic reactions including rash, itching, or swelling.

Before using Guttalax, certain conditions and patient factors should be considered to minimize risks and ensure appropriate use.

• Do not use if you have an intestinal blockage, perforation, or severe inflammatory bowel disease.
• Avoid prolonged or routine use without medical guidance, as dependence may develop.
• Use caution in patients with heart failure, kidney disease, or electrolyte disorders.
• Pregnant or breastfeeding individuals should consult a healthcare professional before use.
• Ensure adequate fluid intake while taking the product to reduce the risk of dehydration.
• Children and elderly may be more sensitive to the effects; dosing adjustments may be required.
• Discontinue use and seek medical advice if symptoms persist beyond 48 hours.

Sodium picosulfate can interact with other medicines or substances that affect fluid balance, electrolyte levels, or gastrointestinal motility.

Avoid

• Other stimulant or osmotic laxatives, which may increase the risk of severe diarrhea and electrolyte loss.
• Anticholinergic drugs that reduce gut motility, potentially diminishing the laxative effect.
• Medications that prolong the QT interval, as electrolyte disturbances can exacerbate cardiac risk.

Use with caution

• Diuretics or antihypertensives, because fluid loss may enhance their blood‑pressure‑lowering effect.
• Mineral supplements (e.g., potassium, magnesium) that could alter electrolyte balance.
• NSAIDs or corticosteroids, which may increase the risk of gastrointestinal irritation.